![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 08, 2021 1:01:36 PM
Dow Jones
(PR) /C O R R E C T I O N from Source -- Hollister Biosciences Inc./
01/08/2021 01:06 AM ET
In the news release, Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019, issued 07-Jan-2021 by Hollister Biosciences Inc. over CNW, we are advised by the company that the title should read "CDN $2.53 Million in EBITDA " rather than "CDN $5.53 Million in EBITDA" as originally issued inadvertently. The complete, corrected release follows:
Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $2.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019
VANCOUVER, BC, Jan. 7, 2021 /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 90 dispensaries throughout Arizona, is pleased to provide an update on its Q4, 2020 performance.
Q4 2020 Update
For the period beginning October 1(st) , 2020 and ending December 31(st) , 2020, Hollister reports that it generated record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA from its product line of pre-rolls, concentrates, distillates, solvent-free bubble hash, pre-packaged flower, tinctures and vape products. The Company cautions that revenue and EBITDA figures have not yet been audited and are based on reports prepared by management.
"We are very pleased with our ability to deliver record quarterly revenue in such a challenging market environment. We attribute our revenue growth to further penetration of the California and Arizona dispensary networks and successful new product launches with our joint venture partners. Sales of cannabis related products continue to show resilience throughout the COVID-19 pandemic. We hope to continue this positive momentum into 2021" stated Alex Somjen, President.
The Venom Extracts ("Venom") branded product suite distributed throughout Arizona has been the primary catalyst for revenue growth of the Company. As of March 26(th) , 2020 (see press release dated March 30th, 2020), Hollister Biosciences acquired Venom. Since the closing, in the three quarters following, Venom contributed approximately CDN$38 million to the company's 2020 revenue. In the entire year of 2020, Venom Extracts generated greater than CDN$ 40 million in revenue (and CDN$ 4.9 million in adjusted EBITDA), up from CDN$ 16.4 million in 2019 a 144% year over year revenue increase, and ending the year with a record month of sales for December totaling approximately CDN$5.5 million.
Venom Extracts sold over 4 million grams of product in 2020 accounting for up to 30 percent of category sales statewide in Arizona. The brand is positioned for continued growth in Arizona with the recently passed adult-use legislation, and endeavors to expand into California and benefit from the company's infrastructure and sales network of over 280 dispensaries. Marijuana Business Daily projects that Arizona's recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024.
In addition to Venom Extracts, Hollister's HashBone pre-rolls are the No. 1 hash-infused pre-roll in California and one of Hollister's signature products. The company recently received trademark approval for the HashBone brand in December. These premium hash-infused pre-rolls feature an artisan blend of 75 percent top-shelf flower and 25 percent cold water bubble hash. Hollister added a new HashBone Minis line in April of 2020. HashBone is now available in 280 dispensaries throughout California, a 40% increase since 2019.
In addition to record revenue growth, the company continued focus on core growth areas; enhancing existing product margins, expanding product penetration and same-store sales in California and Arizona, while continuing to diversify and expand its branded product portfolio. Some highlights of these efforts include completed agreements with Tommy Chong's Cannabis (See press release dated February 7th, 2020) and EasyRiders (See press release dated December 15(th) , 2020) to add to the company's brand suite as well as the launch of the Dreamy Delivery direct-to-consumer platform (see press release dated December 22(nd) , 2020 ) in San Francisco and Sacramento, and ongoing supply chain enhancements are in-review to improve operational efficiency and profit margins by controlling inputs and manufacturing.
The company looks forward to continuing to execute on its business plan and growth targets in 2021 and ahead.
About Hollister Biosciences Inc.
Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand's premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the "American Biker".
Website: www.hollistercannabisco.com
The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.
Anything I post is my opinion only and subject to change on a whimsy
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM